AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19342609
Drug: Peripheral parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral parenteral nutrition without thiamine (n=7)
Trial: 10485530
Drug: Ketorolac ophthalmic
RxNorm normalized name: ketorolac ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac ophthalmic drops 0.5% prescribed four times a day for at least 3 months
Trial: 8934482
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (2 ml containing 40 mg of triamcinolone acetonide + 4 ml of 1% lidocaine without epinephrine)
Trial: 8934482
Drug: Control (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (6 ml of 1% lidocaine without epinephrine)
Trial: 6352169
Drug: Antabuse (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antabuse (50 to 200 mg daily for 6 weeks)
Trial: 24735962
Drug: FC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FC plus subcutaneous alemtuzumab 30 mg on day 1 (FCA)
Trial: 9696518
Drug: Lightbox treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lightbox treatment with 1500-2500 lux white light for 2 h in the morning for 6 days (n=34)
Trial: 9696518
Drug: Dawn simulation
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dawn simulation treatment in their homes, with 60 or 90 min of light augmentation time to 100-300 lux for 2 weeks (n=27)
Trial: 3207528
Drug: Low-dose fentanyl
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fentanyl anaesthesia
Trial: 29158726
Drug: Mineral glycinate
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mineral glycinate complexes + 2 CENs (daily dose: 36 mg iron, 15 mg zinc, 2 mg copper, 2 g carnitine, 400 mg phosphatidylserine)
Trial: 29158726
Drug: Mineral glycinate
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mineral glycinate complexes + 2 CENs (1 g carnitine)
Trial: 24179297
Drug: Social Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Cognitive Therapy (SCT)
Trial: 21173173
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg per os once daily for 5 days
Trial: 21173173
Drug: Clindamycin 300
RxNorm normalized name: clindamycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 300 mg per os four times daily for 5 days
Trial: 15383007
Drug: Eprosartan (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (600 mg)
Trial: 12883365
Drug: SRL172 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRL172 + low-dose IL-2
Trial: 10701731
Drug: Glutamine suspension
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine suspension (16 g in 240 ml normal saline)
Trial: 9412131
Drug: Powdered microcrystalline
RxNorm normalized name: Microcrystalline Cellulose
DrugBank: Microcrystalline cellulose (DB14158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered microcrystalline cellulose dosed 5 g/day for three months
Trial: 8242128
Drug: Corticotrophin-releasing hormone
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotrophin-releasing hormone (CRF) test (1 μg/kg body weight)
Trial: 3519041
Drug: High-dose alizapride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose alizapride (4 mg/kg X five doses)
Trial: 3519041
Drug: High-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide (2 mg/kg X five doses)
Trial: 26315810
Drug: Crushed ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crushed ticagrelor 180 mg (2 tablets, semi-upright position)
Trial: 26315810
Drug: Integral ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integral ticagrelor 180 mg (2 tablets, supine position)
Trial: 20070961
Drug: Rectal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal misoprostol (800 microg at the time of peritoneal incision)
Trial: 20070961
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin infusion (after delivery of the neonate)
Trial: 18788841
Drug: Flumazenil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.5 mg or 1.0 mg)
Trial: 10068575
Drug: Amprenavir (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amprenavir (1200 mg) alone
Trial: 10068575
Drug: Amprenavir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amprenavir with zidovudine (300 mg) plus lamivudine (150 mg)
Trial: 10068575
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (Amprenavir, zidovudine, and lamivudine)
Trial: 6770760
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (30-60 mg/kg per day)
Trial: 6770760
Drug: Phenobarbitone (3-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbitone (3-6 mg/kg per day)
Trial: 16232370
Drug: CSII (Continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII (Continuous Subcutaneous Insulin Infusion) in group CSII-1
Trial: 16232370
Drug: Multiple Injections
RxNorm normalized name: sodium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple Injections (MI) in group MI-1
Trial: 12198064
Drug: ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.5% plus clonidine 7.5 microg/mL (Group 3; n = 13)
Trial: 12198064
Drug: ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.5% plus clonidine 7.5 microg/mL (Group 3)
Trial: 10438346
Drug: Lamivudine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (150 mg 2x/day)
Trial: 10438346
Drug: Lamivudine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (150 mg 2x/day) plus loviride (100 mg 3x/day)
Trial: 7784415
Drug: Isradipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (5 mg for 8 days)
Trial: 27102506
Drug: MRA regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRA regimen with potassium canrenoate (200 mg IV bolus) followed by spironolactone (25 mg once daily for 6 months)
Trial: 23981186
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump therapy with a bolus calculator
Trial: 16167290
Drug: 0.2% sodium
RxNorm normalized name: Dextrose 5% and 0.2% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% sodium naproxen, administered three times a day for 14 days
Trial: 16167290
Drug: 0.1% diclofenac,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% diclofenac, administered three times a day for 14 days
Trial: 9384465
Drug: Ro 48-6791
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 48-6791 (0.1-0.3-1 mg and 1-2-3 mg doses)
Trial: 9384465
Drug: Midazolam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.1 mg kg(-1))
Trial: 1472793
Drug: PSK treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSK treatment
Trial: 6610736
Drug: PRP-D vaccine
RxNorm normalized name: Hib (PRP-D)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-D vaccine (20 micrograms, two injections separated by one month)
Trial: 6610736
Drug: PRP vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP vaccine (20 micrograms, single injection)
Trial: 6610736
Drug: PRP-D vaccine
RxNorm normalized name: Hib (PRP-D)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-D vaccine and PRP vaccine
Trial: 30734018
Drug: Exercise group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise group (standard care plus twice-weekly high-intensity aerobic exercise and resistance training)
Trial: 26582269
Drug: Preparation counseling
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation counseling
Trial: 26582269
Drug: Preparation nicotine
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation nicotine patch
Trial: 26582269
Drug: Preparation nicotine
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation nicotine gum
Trial: 26582269
Drug: 16 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16 weeks of combination nicotine replacement therapy (nicotine patch + nicotine gum)
Trial: 26582269
Drug: 8 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8 weeks of combination nicotine replacement therapy (nicotine patch + nicotine gum)
Trial: 24612282
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate 0.1% ointment (MPA), applied once daily with ¼ fingertip unit for 5 days
Trial: 24612282
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate 0.1% ointment (MPA)
Trial: 22049995
Drug: Interviewer-administered CPQ(8-10)
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administered CPQ(8-10)
Trial: 22049995
Drug: Interviewer-administered CPQ(11-14)
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administered CPQ(11-14)
Trial: 22049995
Drug: Self-administered CPQ(8-10)
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered CPQ(8-10)
Trial: 22049995
Drug: Self-administered CPQ(11-14)
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered CPQ(11-14)
Trial: 14757913
Drug: 48 mg
RxNorm normalized name: betaine 648 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48 mg betahistine
Trial: 2014943
Drug: Aspirin therapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin therapy (325 mg, alternate-day)
Trial: 6385507
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg cimetidine daily in four separate doses (q.i.d.)
Trial: 6385507
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg cimetidine twice a day (b.i.d.)
Trial: 31819291
Drug: Household costs
RxNorm normalized name: costus root oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Household costs associated with P. vivax malaria treatment
Trial: 20652432
Drug: Tuna oil
RxNorm normalized name: tuna oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuna oil (210 mg EPA, 30 mg DPA, 810 mg DHA)
Trial: 20652432
Drug: Seal oil
RxNorm normalized name: seal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seal oil (340 mg EPA, 230 mg DPA, 450 mg DHA)
Trial: 10493085
Drug: Paroxetine 20-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20-50 mg daily
Trial: 1767251
Drug: Phenoxymethylpenicillin dosed
RxNorm normalized name: phenoxymethylpenicillin
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenoxymethylpenicillin dosed three times daily
Trial: 25716539
Drug: Ticagrelor 180
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 180 mg single oral dosage
Trial: 15665769
Drug: Fluvastatin (Lescol)
RxNorm normalized name: fluvastatin Oral Capsule [Lescol]
DrugBank: Fluvastatin (DB01095)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluvastatin (Lescol) 40 mg/day or 80 mg/day
Trial: 10423657
Drug: Cetirizine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (0.2 mg/kg once daily for 28 days)
Trial: 10423657
Drug: Loratadine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (0.2 mg/kg once daily for 28 days)
Trial: 8538704
Drug: Acellular DTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular DTP vaccine (SmithKline Beecham)
Trial: 8538704
Drug: Acellular DTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular DTP vaccine (Chiron Biocine)
Trial: 1866164
Drug: Cytostatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytostatic treatment (Cyclophosphamide, Vincristine, Ftorafur) for 3 months for Group 1 and lifelong systemic treatment for Group 2.
Trial: 1866164
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (67 patients) who had not received chemotherapeutic treatment.
Trial: 7048748
Drug: Lonazolac-Ca (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lonazolac-Ca (200 mg three times daily)
Trial: 7048748
Drug: Naproxen (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (250 mg twice daily plus 1 placebo capsule)
Trial: 18679606
Drug: Modified Xufu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Xufu Zhuyu Decoction (XFZY) plus conventional comprehensive Western medicine
Trial: 18679606
Drug: Conventional comprehensive
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional comprehensive Western medicine
Trial: 12227873
Drug: Isotretinoin 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 0.1% w/w and erythromycin 4.0% w/w gel (Double Strength Isotrexin) once daily
Trial: 12227873
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide 5.0% w/w and erythromycin 3.0% w/w gel (Benzamycin) twice daily
Trial: 12227873
Drug: Isotretinoin/erythromycin gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin/erythromycin gel
Trial: 12227873
Drug: Benzoyl peroxide/erythromycin
RxNorm normalized name: BENZOYL PEROXIDE/ERYTHROMYCIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide/erythromycin gel
Trial: 10215736
Drug: Aspirin 1
RxNorm normalized name: aspirin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 1 g b.d. for 14 days
Trial: 2213396
Drug: Ibuprofen suspension
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen suspension at a dosage of 30 to 40 mg/kg/day
Trial: 2213396
Drug: Aspirin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin at a dosage of 60 to 80 mg/kg/day
Trial: 2213396
Drug: Ibuprofen suspension
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen suspension (30, 40, and 50 mg/kg/day) in a 24-week open trial
Trial: 11826230
Drug: Ibuprofen suspension
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen suspension
Trial: 31888938
Drug: Short text
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short text messages three times a week for 6 months designed to improve medication adherence.
Trial: 28872920
Drug: Edaravone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone (60 mg intravenous)
Trial: 21849011
Drug: Discontinue medication
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinue medication (Group A)
Trial: 21849011
Drug: 2-month additional
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 2-month additional medication (Group B)
Trial: 21849011
Drug: 5-month additional
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-month additional medication (Group C)
Trial: 11482041
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (omeprazole, amoxicillin, clarithromycin)
Trial: 11482041
Drug: Omeprazole plus
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole plus antibiotic placebo
Trial: 11482041
Drug: Ranitidine placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine placebo (after initial treatment)
Trial: 11482041
Drug: Ranitidine (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (after initial treatment)
Trial: 9824409
Drug: SIT (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT (subcutaneous immunotherapy) for birch pollen for 12, 24, or 36 months
Trial: 9824409
Drug: SIT (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT (subcutaneous immunotherapy) for birch pollen
Trial: 2496052
Drug: abortive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: abortive therapy with ergotamine tartrate plus caffeine (standard abortive therapy)
Trial: 2496052
Drug: standard abortive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard abortive therapy accompanied by a brief educational intervention
Trial: 26182059
Drug: Kinect-based exergame,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kinect-based exergame, played once or twice a week, up to a total of 24 times
Trial: 28575467
Drug: Doxepin 6
RxNorm normalized name: doxepin 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin 6 mg
Trial: 21722958
Drug: Doxepin 50
RxNorm normalized name: doxepin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin 50 mg
Trial: 8602314
Drug: Estrogen-progestin preparation
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen-progestin preparation
Trial: 1761336
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral aspirin
Trial: 7067071
Drug: Intranasal flunisolide
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal flunisolide (300 micrograms/day)
Trial: 3882355
Drug: trimethoprim-sulfamethopyrazine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trimethoprim-sulfamethopyrazine (2 capsules of 250 mg trimethoprim + 200 mg sulfamethopyrazine per capsule on the 1st day and 1 capsule for the following 14 days)
Trial: 3882355
Drug: trimethoprim-sulfamethoxazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trimethoprim-sulfamethoxazole (2 capsules of trimethoprim 80 mg + sulfamethoxazole 400 mg per capsule twice daily for 15 days)
Trial: 24926954
Drug: Intraduodenal L-tryptophan
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraduodenal L-tryptophan (L-Trp) at 0.075 kcal/min (total 6.75 kcal)
Trial: 24926954
Drug: Intraduodenal L-tryptophan
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraduodenal L-tryptophan (L-Trp) at 0.15 kcal/min (total 13.5 kcal)
Trial: 18419949
Drug: Urapidil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (5 mg) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection.
Trial: 18419949
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl (5 ml) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection (Control group).
Trial: 16227864
Drug: Multiple interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple interventions assessed alone or in combination
Trial: 10394020
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B colloidal dispersion (ABCD), median cumulative dose 4050 mg, median duration 18 days
Trial: 7555617
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg or 25 mg ketoprofen
Trial: 7555617
Drug: 275 mg
RxNorm normalized name: kava root 275 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 275 mg naproxen sodium
Trial: 72290
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg oxprenolol
Trial: 28114922
Drug: Twice-weekly home
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly home monitoring of symptoms (CFRSD-CRISS and FEV1)
Trial: 25669933
Drug: Everolimus combined
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus combined with lower dose tacrolimus
Trial: 25669933
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control (combination regimen minus everolimus)